Dr. Harald Schnidar, CEO & Founder of SCARLETRED, will attend the BIO International Convention 2026 from June 22–25, 2026, in San Diego, California. As the largest event for biotechnology, BIO 2026 unites over 20.000 industry leaders, investors, and innovators from across the globe.

Where the future of healthcare takes shape

Taking place at the San Diego Convention Center, BIO 2026 features over 130 sessions across 18 focus areas, covering everything from AI and clinical innovation to diagnostics and global market development. It remains the essential meeting point for the life sciences ecosystem.

Dr. Schnidar, CEO and Founder of SCARLETRED, will meet with innovators, partners, and decision-makers across biotech and pharma to discuss how standardized, evidence-based skin data can support clinical development, objectively demonstrate treatment outcomes, and strengthen asset value in partnering and out-licensing discussions - with a particular focus on digital biomarkers, decentralized clinical research, and medically certified smartphone-based imaging and AI-powered analysis.

As the founder of both SCARLETRED Holding GmbH in Vienna and SCARLETRED Inc. in Cambridge, Massachusetts, Dr. Schnidar brings years of cross-continental MedTech expertise to every partnership conversation. Attendees can schedule an in-person meeting with him directly via BIO Partnering here.

SCARLETRED looks forward to the conversations, connections, and collaborations that BIO 2026 will bring.